Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Find out which cash back cards offer the best options for 2023. Stay updated with the latest offerings to maximize your rewards.
26,992 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
A single company’s three engines—cloud, ads, and chips—are powering a persistent multi‑billion revenue trajectory, ev...
When bitcoin dips under $70k amid a sharp stock sell-off tied to a hawkish FED hold, traders scramble for direction. ...
When the Fed signals a path to price stability, Bitcoin often takes a hit before buyers step in. This article breaks ...
A 73-year-old worker with an $800,000 401(K) cannot roll it into a new IRA after leaving a former employer, revealing...
As Micron Technology rides AI-driven memory demand, investors debate a bold forecast. Market models suggest a potenti...
Bitcoin miners start funding AI pivots by borrowing and selling BTC to stay liquid as margins tighten, hash prices fa...
The GENIUS Act creates a federal framework for dollar-backed stablecoins, setting rules on issuance, reserve backing,...
Stocks rose Tuesday as AI momentum outweighed inflation jitters, with fresh analyst calls on Autodesk, Celanese, DexC...
Markets can climb for years, but today’s warning signs hint at a tougher road ahead. This guide breaks down the histo...
AMD’s latest earnings reinforce its role in the AI infrastructure wave, setting up this stock biggest bet for May as ...
As IPO activity spikes, investors wonder if history is rhyming with 1929 and 2000. This guide breaks down the signals...